Thallium201ChlorideQualityChecker

Thallium-201 Chloride

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity Tc-99m
Open selection

Utility description: Thallium-201 Chloride

Thallium-201 Chloride Quality Checker — Thallium-201 Chloride for Cardiology and Oncology

ℹ️  Utility checks critical parameters of Thallium-201:
    • Radionuclidic purity (≥99.5%)
    • Thallium-200 impurity (≤0.5%)
    • Thallium-202 impurity (≤0.5%)
    • Radiochemical purity (≥98%, Tl+ ion)
    • pH, endotoxins, sterility, heavy metals

⚠️  CRITICAL: Thallium-201 must be in the form of free ion (Tl+)!
    Only the ionic form is taken up by myocyte Na/K-ATPase.

Usage:
  Thallium201ChlorideQualityChecker.exe                            → demo mode (console output)
  Thallium201ChlorideQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Thallium200ImpurityPercent,Thallium202ImpurityPercent,RadiochemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType

Example (sterility: 0=sterile, 1=contaminated):
  TL201-CL-2026-120,111.0,99.8,0.1,0.05,99.5,6.0,20.0,0,2,MyocardialPerfusion

Supported product types:
• MyocardialPerfusion — myocardial perfusion (viability, ischemia)
• TumorImaging — tumor imaging (parathyroid glands, brain)

— WHY IS THIS NEEDED?
Thallium-201 (T½=73 hours) is a unique radiopharmaceutical that behaves as a potassium (K+) analog:
• Actively transported into cells via Na+/K+-ATPase
• Cardiology: Gold standard for assessing myocardial viability (hibernating myocardium). Uptake depends on blood flow and metabolic activity of cells.
• Oncology: Used for imaging parathyroid tumors (adenomas), some brain and lung tumors, as they actively accumulate thallium.
• Emits mercury X-rays (69-83 keV), suitable for gamma cameras.

⚠️  CRITICAL:
• Radiochemical purity ≥98% (Tl+ Ion) — DRUG MUST BE IN THE FORM OF THALLOUS CHLORIDE (TlCl). Any complexes or colloidal forms will not be taken up by cells via potassium channels. This is a fundamental difference from technetium drugs.
• Radionuclidic purity ≥99.5% — Presence of other thallium isotopes is unacceptable.
• Thallium-200 (T½=26.1 h) impurity ≤0.5% — Tl-200 emits high-energy gamma quanta, increasing patient radiation dose and creating image noise.
• Thallium-202 (T½=12.3 d) impurity ≤0.5% — Long-lived impurity creating long-term radiation burden.
• pH 4.0–7.5, Endotoxins ≤175 EU/vial, Sterility — standard requirements.
• Heavy metals ≤10 ppm — Standard purity control.

Key features:
• Control of specific thallium isotopic impurities (Tl-200, Tl-202)
• Strict control of ionic form (Radiochemical Purity as Tl+)
• Assessment of suitability for cardiac and oncologic diagnosis

Critical parameters:
• Radionuclidic purity: ≥99.5%
• Tl-200 impurity: ≤0.5%
• Tl-202 impurity: ≤0.5%
• Radiochemical purity (Tl+): ≥98.0%
• pH: 4.0–7.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm

💡 Usage tips:
1. Thallium-201 is produced in a cyclotron (protons on lead or bismuth target, or enriched thallium). Impurity control depends on target purity and beam energy.
2. The drug is stable for a long time (weeks), but usually used within a few days after release due to decay.
3. For cardiology, stress and rest tests are performed with an interval, using thallium redistribution.
4. Tl-201 has a higher radiation dose to the patient compared to Tc-99m agents, so it is used strictly according to indications (viability assessment).

⚠️ Note: Thallium-201 is not just a blood flow indicator, but an indicator of METABOLIC ACTIVITY and cell membrane integrity. If a cell is dead (necrosis), it will not accumulate thallium, even if blood flow is restored. This makes it indispensable for assessing myocardial viability before revascularization.

input.csv

BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Thallium200ImpurityPercent,Thallium202ImpurityPercent,RadiochemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
TL201-CL-2026-120,111.0,99.8,0.1,0.05,99.5,6.0,20.0,0,2,MyocardialPerfusion
TL201-CL-FAIL-121,100.0,98.0,1.5,0.8,95.0,5.5,30.0,0,5,MyocardialPerfusion
TL201-CL-TUMOR-122,74.0,99.9,0.05,0.02,99.8,6.5,10.0,0,1,TumorImaging

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Thallium201ChlorideQualityChecker for Thallium-201 Chloride.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of Thallium-201:
  • • Radionuclidic purity (≥99.5%)
  • • Thallium-200 impurity (≤0.5%)
  • • Thallium-202 impurity (≤0.5%)
  • • Radiochemical purity (≥98%, Tl+ ion)
  • • pH, endotoxins, sterility, heavy metals
  • ⚠️ CRITICAL: Thallium-201 must be in the form of free ion (Tl+)!
  • BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Thallium200ImpurityPercent,Thallium202ImpurityPercent,RadiochemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
  • Example (sterility: 0=sterile, 1=contaminated):
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥98% (Tl+ Ion) — DRUG MUST BE IN THE FORM OF THALLOUS CHLORIDE (TlCl). Any complexes or colloidal forms will not be taken up by cells via potassium channels. This is a fundamental difference from technetium drugs.
  • • Radionuclidic purity ≥99.5% — Presence of other thallium isotopes is unacceptable.
  • • Thallium-200 (T½=26.1 h) impurity ≤0.5% — Tl-200 emits high-energy gamma quanta, increasing patient radiation dose and creating image noise.
  • • Thallium-202 (T½=12.3 d) impurity ≤0.5% — Long-lived impurity creating long-term radiation burden.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Thallium-201 Chloride using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringTL201-CL-2026-120Batch or lot identifier used for traceability.
2TotalActivityMBqdecimal111.0Radioactivity value used for release, decay or dose-related assessment.
3RadionuclidicPurityPercentstring99.8Radionuclidic purity; a critical radiation-safety and impurity parameter.
4Thallium200ImpurityPercentstring0.1Controlled impurity or residual material.
5Thallium202ImpurityPercentstring0.05Controlled impurity or residual material.
6RadiochemicalPurityPercentstring99.5Radiochemical purity; confirms the labelled chemical form and binding quality.
7pHdecimal6.0Solution pH; relevant for stability, compatibility and administration.
8EndotoxinsEUdecimal20.0Bacterial endotoxins; critical for parenteral administration.
9SterilityTestflag / boolean0Sterility result; critical release parameter.
10HeavyMetalsPPMdecimal2Elemental impurity / metal residue parameter.
11ProductTypestringMyocardialPerfusionControlled input parameter used by the deterministic QC rules.
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Thallium200ImpurityPercent,Thallium202ImpurityPercent,RadiochemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
TL201-CL-2026-120,111.0,99.8,0.1,0.05,99.5,6.0,20.0,0,2,MyocardialPerfusion
TL201-CL-FAIL-121,100.0,98.0,1.5,0.8,95.0,5.5,30.0,0,5,MyocardialPerfusion
TL201-CL-TUMOR-122,74.0,99.9,0.05,0.02,99.8,6.5,10.0,0,1,TumorImaging

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Thallium-201 Chloride, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "thallium201-chloride-quality-checker",
  "api": "Thallium-201 Chloride",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "TL201-CL-2026-120",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "TotalActivityMBq",
      "value": "111.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityPercent",
      "value": "99.8",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Thallium200ImpurityPercent",
      "value": "0.1",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Thallium202ImpurityPercent",
      "value": "0.05",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "99.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "6.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "20.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Cardiology QC Suite

QC package for cardiology medicines: antihypertensives, anticoagulants, antiplatelets, lipid-lowering and antiarrhythmic medicines plus supporting QC checks.

Open

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Gastroenterology QC Suite

QC package for gastroenterology: PPIs, antiemetics, prokinetics, IBD medicines, laxatives, enzymes and GI anti-infectives.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: cardiac perfusion and generator tracers

Rb-82/Sr-82, N-13 and Tl-201 for myocardial perfusion and generator-supported workflows.

Open

RPH isotope family: Tc-99m

Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: cardiovascular

Myocardial perfusion, cardiac PET/SPECT, ventricular function, blood-pool and perfusion tracers.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH organ/system: pulmonary and ventilation

Lung perfusion, MAA, V/Q, aerosol, xenon ventilation, shunt and pulmonary dosimetry.

Open

RPH use case: cardiac, bone and classic SPECT radiopharmaceuticals

Sestamibi, tetrofosmin, MDP, pyrophosphate, thallium and related quality checks for cardiology, bone imaging and classic SPECT protocols.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: instruments, devices and radiation safety

PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open